Related Research Articles
Josep Baselga i Torres, known in Spanish as José Baselga was a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents, with a special emphasis in breast cancer. Through his career he was associated with the Memorial Sloan Kettering Cancer Center, Vall d'Hebron Institute of Oncology, and the Massachusetts General Hospital in their hematology and oncology divisions. He led the development of the breast cancer treatment Herceptin, a monoclonal antibody, that targets the HER2 protein which is impacted in aggressive breast cancers.
Charles L. Sawyers is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.
Joan Massagué, is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.
Aviv Regev is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche. She is a core member at the Broad Institute of MIT and Harvard and professor at the Department of Biology of the Massachusetts Institute of Technology. Regev is a pioneer of single cell genomics and of computational and systems biology of gene regulatory circuits. She founded and leads the Human Cell Atlas project, together with Sarah Teichmann.
Thomas J. Kelly is an American cancer researcher whose work focuses on the molecular mechanisms of DNA replication. Kelly is director of the Sloan-Kettering Institute, the basic research arm of the Memorial Sloan-Kettering Cancer Center. He holds the Center's Benno C. Schmidt Chair of Cancer Research.
Bruce William Stillman, AO, FAA, FRS is a biochemist and cancer researcher who has served as the Director of Cold Spring Harbor Laboratory (CSHL) since 1994 and President since 2003. He also served as the Director of its NCI-designated Cancer Center for 25 years from 1992 to 2016. During his leadership, CSHL has been ranked as the No. 1 institution in molecular biology and genetics research by Thomson Reuters. Stillman's research focuses on how chromosomes are duplicated in human cells and in yeast Saccharomyces cerevisiae; the mechanisms that ensure accurate inheritance of genetic material from one generation to the next; and how missteps in this process lead to cancer. For his accomplishments, Stillman has received numerous awards, including the Alfred P. Sloan, Jr. Prize in 2004 and the 2010 Louisa Gross Horwitz Prize, both of which he shared with Thomas J. Kelly of Memorial Sloan-Kettering Cancer Center, as well as the 2019 Canada Gairdner International Award for biomedical research, which he shared with John Diffley.
James Patrick Allison is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas.
Taekjip Ha is a South Korean-born American biophysicist who is currently a Bloomberg Distinguished Professor of Biophysics and Biomedical Engineering at Johns Hopkins University. He was previously the Gutgsell Professor of Physics, at University of Illinois at Urbana-Champaign where he was the principal investigator of Single Molecule Nanometry group. He is also a Howard Hughes Medical Institute investigator.
Roger Sidney Goody is an English biochemist who served as director at the Max Planck Institute for Molecular Physiology in Dortmund from 1993 until 2013. Since 2013 he is Emeritus Director of the institute.
Dana Pe'er is currently the Chair and Professor in Computational and Systems Biology Program at Sloan Kettering Institute, and regarded as one of the leading researchers in computational systems biology. She was selected as a Howard Hughes Medical Institute (HHMI) Investigator in September, 2021. Previously, she was a professor at Columbia Department of Biological Sciences. Pe'er's research focuses on understanding the organization, function and evolution of molecular networks, particularly how genetic variations alter the regulatory network and how these genetic variations can cause cancer.
Scott William Lowe is Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is recognized for his research on the tumor suppressor gene, p53, which is mutated in nearly half of cancers.
Professor Carol L. Prives FRS is the Da Costa Professor of Biological Sciences at Columbia University. She is known for her work in the characterisation of p53, an important tumor suppressor protein frequently mutated in cancer.
Brenda Schulman is an American biochemist and structural biologist who is a Director at the Max Planck Institute of Biochemistry. Schulman's research interests focus on a class of proteins known as ubiquitin-like proteins.
Gregory James Hannon is a professor of molecular cancer biology and director of the Cancer Research UK Cambridge Institute at the University of Cambridge. He is a Fellow of Trinity College, Cambridge while also serving as a director of cancer genomics at the New York Genome Center and an adjunct professor at Cold Spring Harbor Laboratory.
Jeffrey Drebin is a surgeon and scientist. He serves as the Department of Surgery Chair at Memorial Sloan Kettering.
Dinshaw Patel is an Indian-American structural biologist who holds the Abby Rockefeller Mauzé Chair in Experimental Therapeutics at Memorial Sloan Kettering Cancer Center in New York City.
Leemor Joshua-Tor is the W.M. Keck Professor of Structural Biology at Cold Spring Harbor Laboratory and a Howard Hughes Medical Institute Investigator. Her research focuses on the role of the argonaute complex in RNA interference.
Maria Jasin is a molecular biologist at Memorial Sloan Kettering Cancer Center. Her lab studies homologous recombination, a method in which breaks in DNA strands are repaired. She is an elected member of the National Academy of Sciences and the American Academy of Arts and Sciences.
Barry H. Honig is an American biochemist, molecular biophysicist, and computational biophysicist, who develops theoretical methods and computer software for "analyzing the structure and function of biological macromolecules."
Scott Neal Keeney is an American molecular biologist.
References
- ↑ "The Nikola Pavletich Lab - Memorial Sloan Kettering Cancer Center". www.mskcc.org.
- ↑ "Nikola Pavletich, PhD - Tri-Institutional PhD Program in Chemical Biology".
- 1 2 3 "Two Memorial Sloan Kettering Investigators Named to National Academy of Sciences - Gerstner Sloan Kettering Graduate School of Biomedical Sciences". www.sloankettering.edu.
- ↑ "Nikola P. Pavletich, PhD Research Abstract - HHMI.org".
- ↑ "Nikola P. Pavletich, Ph.D." www.pewtrusts.org.
- ↑ "Nikola P. Pavletich". Arnold and Mabel Beckman Foundation. Retrieved 1 August 2018.
- ↑ Review, MIT Technology. "Innovator Under 35: Nikola Pavletich, 33". MIT Technology Review.
- ↑ https://www.amacad.org/multimedia/pdfs/alphalist2014.pdf [ bare URL PDF ]
- ↑ "National Academy of Medicine Elects New Members - The ASCO Post". www.ascopost.com.